<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The association of <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> with <z:hpo ids='HP_0001409'>portal hypertension</z:hpo>, also called portopulmonary <z:hpo ids='HP_0000822'>hypertension</z:hpo>, is a well-described condition </plain></SENT>
<SENT sid="1" pm="."><plain>The pathogenesis of this association remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a 34-year-old female patient with "<z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e>" and portopulmonary <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Our finding supports that in situ microthrombosis associated with the presence of anticardiolipin antibodies could be the pathophysiologic explanation for both portal and <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
</text></document>